Novo Nordisk

Novo Nordisk is a leading global healthcare company specializing in diabetes care and other serious chronic conditions. Founded in Denmark nearly a century ago, the company has earned recognition for its innovative treatments, including groundbreaking GLP-1 therapies for diabetes and obesity. Beyond medications, Novo Nordisk is committed to sustainability, aiming for zero environmental impact by 2045. The company also focuses on rare blood disorders and expanding access to healthcare worldwide. Through continuous research and patient-centered solutions, Novo Nordisk remains at the forefront of medical innovation while improving lives across the globe.